The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial
Dogar O, Barua D, Böckmann M, Elsey H, Fatima R, Gabe R, Huque R, Keding A, Khan A, Kotz D, Kralikova E, et al. (2018)
Addiction 113(9): 1716-1726.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
add.14242.pdf
1.07 MB
Autor*in
Dogar, Omara;
Barua, Deepa;
Böckmann, MelanieUniBi 
;
Elsey, Helen;
Fatima, Razia;
Gabe, Rhian;
Huque, Rumana;
Keding, Ada;
Khan, Amina;
Kotz, Daniel;
Kralikova, Eva;
Newell, James N.
Alle
;
Elsey, Helen;
Fatima, Razia;
Gabe, Rhian;
Huque, Rumana;
Keding, Ada;
Khan, Amina;
Kotz, Daniel;
Kralikova, Eva;
Newell, James N.
Alle
Alternativer Titel
TB and Tobacco trial
Erscheinungsjahr
2018
Zeitschriftentitel
Addiction
Band
113
Ausgabe
9
Seite(n)
1716-1726
Urheberrecht / Lizenzen
ISSN
0965-2140
Page URI
https://pub.uni-bielefeld.de/record/2943862
Zitieren
Dogar O, Barua D, Böckmann M, et al. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction. 2018;113(9):1716-1726.
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), 1716-1726. https://doi.org/10.1111/add.14242
Dogar, Omara, Barua, Deepa, Böckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, et al. 2018. “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”. Addiction 113 (9): 1716-1726.
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., et al. (2018). The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction 113, 1716-1726.
Dogar, O., et al., 2018. The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction, 113(9), p 1716-1726.
O. Dogar, et al., “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”, Addiction, vol. 113, 2018, pp. 1716-1726.
Dogar, O., Barua, D., Böckmann, M., Elsey, H., Fatima, R., Gabe, R., Huque, R., Keding, A., Khan, A., Kotz, D., Kralikova, E., Newell, J.N., Nohavova, I., Parrott, S., Readshaw, A., Renwick, L., Sheikh, A., Siddiqi, K.: The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial. Addiction. 113, 1716-1726 (2018).
Dogar, Omara, Barua, Deepa, Böckmann, Melanie, Elsey, Helen, Fatima, Razia, Gabe, Rhian, Huque, Rumana, Keding, Ada, Khan, Amina, Kotz, Daniel, Kralikova, Eva, Newell, James N., Nohavova, Iveta, Parrott, Steve, Readshaw, Anne, Renwick, Lottie, Sheikh, Aziz, and Siddiqi, Kamran. “The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients-protocol for a double-blind, placebo-controlled randomized trial”. Addiction 113.9 (2018): 1716-1726.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung - Nicht kommerziell - Keine Bearbeitungen 4.0 International (CC BY-NC-ND 4.0):
Volltext(e)
Name
add.14242.pdf
1.07 MB
Access Level
Open Access
Zuletzt Hochgeladen
2021-06-22T05:44:20Z
MD5 Prüfsumme
4c522a01641ebc78680a04ca014358ee
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 29676824
PubMed | Europe PMC
Suchen in
Google Scholar